Biowel is engaged with Lonza since over a decade. Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. They focus on enabling treatments that prevent illness and support healthier lifestyles. Optimising scientific innovation and manufacturing technology enable Lonza’s customers to serve their patients and consumers.

The portfolio includes primary cells, specialised medias and reagents, endotoxin testing, stem cell research products, transfection technologies, electrophoresis and bio assays.